EGFR is a valuable therapeutic target for CRC, and EGFR inhibitors are effective drugs for the treatment of metastatic CRC [35], suggesting that curcumin may be used to treat metastatic CRC by inhibiting EGFR. The gene discussed is EGFR; the disease is colorectal carcinoma.